Massive study closes in on cancers risk markers

May 15, 2013, CORDIS
Massive study closes in on cancers risk markers

Cancer research has taken a huge leap forward with scientists now able to identify more than 80 genetic markers found to increase the risk of breast, ovarian and prostate cancer. The COGS international research initiative is believed to be the largest of its kind.

Although the results have been widely reported, the cross-border efforts behind this monumental initiative have not. Neither has the EU-funding of EUR 12 million, which has played a significant part in making this global effort a tremendous success. The main findings of the project COGS ('Collaborative Oncological Gene-Environment Study') have been published in a special issue on for cancer in the prestigious scientific journal Nature Genetics.

The research was led by scientists at the Karolinska Institutet in Sweden, the University of Cambridge and the Institute of (ICR) in the UK, with support from more than 160 research groups worldwide. This international network brought together five global studies on 100 000 patients with breast, ovarian or . Another 100 000 healthy volunteers comprised a control group.

Scientists took DNA from all 200 000 subjects and compared those with cancer, and those without, to assess each individual's inherited risk.

Overall, the study found that links all these cancers. This can be described as a genetic 'spelling mistake', where an A, G, C or T in the has been replaced with another letter. The spelling mistake is called Single Nucleotide Polymorphism (SNP).

Each alteration was seen to raise the risk of ovarian, breast or prostate cancer by a small amount, although a small minority of men with several markers saw their risk of prostate cancer increase more than fourfold. Prostate cancer is the second most common cancer in men worldwide, contributing to 14 % of all new cancer cases. It is predicted that the number of cases will almost double to a figure of 1.7 million by 2030.

Results of the studies on women revealed that with certain spelling mistakes the risk of , which affects 28 % of women in Europe, increased threefold. In addition, the test also identified those with a smaller than average risk of developing the cancers.

Breast cancer is usually diagnosed at a more advanced stage, but scientists believe this research could also help the one in 300 women who carry a faulty gene known as BRCA1 or BRCA2.

One of the study authors, Professor Doug Easton from the University of Cambridge who led several of the studies, said: 'We're on the verge of being able to use our knowledge of these genetic variations to develop a test that could complement breast cancer screening and take us a step closer to having an effective prostate cancer screening programme.'

With this new information, researchers now have a clearer picture of the total number of genetic changes that can explain the risk of getting these cancers. The next step is to calculate the individual cancer risk, which will help to better understand how these cancers start and grow so that new treatments can be developed. It is possible this could lead to a DNA screening test within five years.

COGS coordinator Professor Per Hall from the Karolinska Institutet says: 'COGS is the largest genotyping project in the world targeting identification of genetic changes that influence the risk of common cancers. The collaborative efforts have been tremendous and the key to its success.'

Other financial contributors to the COGS project are the Märit and Hans Rausing Initiative against Breast Cancer, the Swedish Research Council, Cancer Research UK and the Risk Prediction Center (CRisP).

Explore further: Unique study reveals genetic 'spelling mistakes' that increase the risk of common cancers

More information: COGS www.cogseu.org
www.nature.com/icogs/

Related Stories

Unique study reveals genetic 'spelling mistakes' that increase the risk of common cancers

March 27, 2013
More than 80 genetic 'spelling mistakes' that can increase the risk of breast, prostate and ovarian cancer have been found in a large, international research study within the framework of the EU Network COGS. For the first ...

Five genetic variations increase risk of ovarian cancer

March 27, 2013
An international research collaboration has found five new regions of the human genome that are linked to increased risks for developing ovarian cancer. Duke Medicine researchers played a leading role analyzing genetic information ...

New DNA sequences hone in on breast, ovarian cancer risk

March 27, 2013
Researchers at Mayo Clinic Cancer Center have identified new DNA sequences associated with breast cancer—the most common cancer among women, with an average risk of developing the disease of 10 percent—and ovarian cancer, ...

Novel gene drives development of different types of ovarian cancer

March 27, 2013
Researchers at Mayo Clinic Cancer Center have identified a novel gene that can contribute to a woman's susceptibility for developing ovarian cancer. Researchers identified the gene, called HNF1B, through large-scale analysis ...

Surgery can dramatically reduce genetic cancer risk

May 14, 2013
Women whose genes put them at a high risk of contracting breast cancer can dramatically reduce the danger by having a double mastectomy—but not eliminate it altogether, experts say.

Gene mutation as cause of breast and ovarian cancer

May 10, 2013
A change to the so-called TERT gene considerably increases the risk of breast and ovarian cancer. This is the result of a current, multicenter study in which the University Department of Gynaecology and the Comprehensive ...

Recommended for you

Epigenetics study helps focus search for autism risk factors

January 16, 2018
Scientists have long tried to pin down the causes of autism spectrum disorder. Recent studies have expanded the search for genetic links from identifying genes toward epigenetics, the study of factors that control gene expression ...

Group recreates DNA of man who died in 1827 despite having no body to work with

January 16, 2018
An international team of researchers led by a group with deCODE Genetics, a biopharmaceutical company in Iceland, has partly recreated the DNA of a man who died in 1827, despite having no body to take tissue samples from. ...

The surprising role of gene architecture in cell fate decisions

January 16, 2018
Scientists read the code of life—the genome—as a sequence of letters, but now researchers have also started exploring its three-dimensional organisation. In a paper published in Nature Genetics, an interdisciplinary research ...

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

How incurable mitochondrial diseases strike previously unaffected families

January 15, 2018
Researchers have shown for the first time how children can inherit a severe - potentially fatal - mitochondrial disease from a healthy mother. The study, led by researchers from the MRC Mitochondrial Biology Unit at the University ...

Genes that aid spinal cord healing in lamprey also present in humans

January 15, 2018
Many of the genes involved in natural repair of the injured spinal cord of the lamprey are also active in the repair of the peripheral nervous system in mammals, according to a study by a collaborative group of scientists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.